6.79
-0.22 (-3.14%)
-0.22 (-3.14%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.6018
High
10.15
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Scynexis Inc | SCYX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.22 | -3.14% | 6.79 | 17:56:24 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.06 | 6.685 | 7.13 | 6.79 | 7.01 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 6.83 | 6.85 | 0.02 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,215 | 184,480 | $ 6.91 | $ 1,275,593 | 298,200 | 0.6018 - 10.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:50:36 | 3 | $ 6.80 | USD |
Scynexis Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 140.08M | 20.63M | 15.82M | $ - | $ - | -5.40 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 330.00k | 2.00% |
Scynexis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SCYX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.22 | 7.26 | 6.36 | 6.86 | 263,111 | -0.43 | -5.96% |
| 1 Month | 7.90 | 7.98 | 6.36 | 7.35 | 310,310 | -1.11 | -14.05% |
| 3 Months | 9.29 | 9.35 | 6.36 | 8.09 | 395,788 | -2.50 | -26.91% |
| 6 Months | 5.46 | 10.15 | 5.30 | 7.88 | 492,061 | 1.33 | 24.36% |
| 1 Year | 0.873 | 10.15 | 0.6018 | 5.08 | 425,205 | 5.92 | 677.78% |
| 3 Years | 1.28 | 10.15 | 0.35 | 2.05 | 618,701 | 5.51 | 430.47% |
| 5 Years | 3.91 | 10.15 | 0.35 | 2.21 | 528,699 | 2.88 | 73.66% |
Scynexis Description
| SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing a lead product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains. |
